PFIZER INC
PFENYSETrading Snapshot
- Day Range
- $29.22 – $29.82
- 52-Week Range
- $23.62 – $30.44
- Volume (shares)
- 27,238,173
- Avg Volume (shares)
- —
- Shares Outstanding
- 5.70B
- Next Earnings
- 2026-11-03
Fundamentals Snapshot
- Annual Revenue
- $62.58B
- Last Q Revenue
- $15.03B
- P/E Ratio
- 39.2
- P/S Ratio
- 2.7x
- EPS (TTM)
- $0.76
- Dividend Yield
- 5.77%
- Dilution (1yr)
- −0.3%
PFIZER INC
PFE
StockOtter · stockotter.spaceAbout PFIZER INC
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Latest News & Updates
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
Pfizer (PFE) closed at $29.45 in the latest trading session, marking a -1.17% move from the prior day.
Pfizer Stock Ahead of Q3 Earnings: To Buy or Not to Buy?
Pfizer heads into Q3 earnings with strong drug sales and an attractive valuation, but declining COVID revenues and looming patent expirations pose challenges.
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
The stocks listed here yield up to 5.8%.
Pfizer Cancer Therapy Shows Extended Progression-Free Survival in Multiple Myeloma Patients
Pfizer Inc. (NYSE:PFE) on Tuesday released topline results from its Phase 3 MagnetisMM-32 study evaluating Elrexfio (elranatamab) as a monotherapy.
$200,000 in Dividend Stocks: How Much More Could You Keep in a Roth IRA?
Parking six popular dividend stocks in a taxable account quietly hands the IRS a cut of every payout, and one holding in your portfolio is almost certainly the biggest culprit.
Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?
Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.